Abstract
Poster session 3, September 23, 2022, 12:30 PM - 1:30 PM The National Institute of Allergy and Infectious Diseases (NIAID) funds one of the largest medical mycology research portfolios. The portfolio includes the major human fungal pathogens and covers basic fungal biology and the more translational areas of therapeutics, vaccines, and diagnostics. NIAID utilizes many granting mechanisms that are open to US and international researchers. These include investigator-initiated applications (R01, R21, and R03s) and targeted announcements for fungal research. Additionally, NIAID has a suite of preclinical services supporting therapeutic, diagnostic, and vaccine development. These services are free and available to investigators in academia, not-for-profit organizations, industry, or governments worldwide. The NIAID granting mechanism can be complicated. Tips and tricks for navigating the NIAID application process and preclinical services will be discussed.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
